- Report
- October 2025
- 88 Pages
Global
From €3985EUR$4,500USD£3,414GBP
- Report
- October 2025
- 80 Pages
Global
From €3985EUR$4,500USD£3,414GBP
- Report
- October 2025
- 90 Pages
Global
From €3985EUR$4,500USD£3,414GBP
- Report
- April 2026
Middle East, Africa
From €4250EUR$4,799USD£3,641GBP
- Report
- May 2026
- 80 Pages
Europe
From €2878EUR$3,250USD£2,466GBP
- Report
- May 2026
- 76 Pages
Asia Pacific
From €2878EUR$3,250USD£2,466GBP
- Report
- February 2026
- 75 Pages
Europe
From €2878EUR$3,250USD£2,466GBP
- Report
- September 2025
- 85 Pages
United States
From €3099EUR$3,500USD£2,656GBP
- Report
- August 2025
- 84 Pages
United States
From €3099EUR$3,500USD£2,656GBP
- Report
- April 2026
- 87 Pages
United States
From €2524EUR$2,850USD£2,162GBP
- Report
- March 2026
- 208 Pages
United States
From €4295EUR$4,850USD£3,680GBP
- Report
- March 2026
- 199 Pages
United States
From €4295EUR$4,850USD£3,680GBP
- Report
- November 2025
- 70 Pages
Africa, Middle East
From €3055EUR$3,450USD£2,618GBP
- Report
- October 2025
- 85 Pages
Middle East
From €3985EUR$4,500USD£3,414GBP
- Report
- October 2025
- 87 Pages
United States
From €3985EUR$4,500USD£3,414GBP
- Report
- October 2025
- 97 Pages
Asia Pacific
From €3985EUR$4,500USD£3,414GBP
- Report
- October 2025
- 80 Pages
Middle East
From €3985EUR$4,500USD£3,414GBP
From €3985EUR$4,500USD£3,414GBP
- Report
- October 2025
- 100 Pages
Middle East
From €3985EUR$4,500USD£3,414GBP
- Report
- September 2025
- 95 Pages
United States
From €3985EUR$4,500USD£3,414GBP

The Targeted Therapies market within the context of Genomics is focused on the development of treatments that target specific genetic mutations or pathways. These therapies are designed to be more effective and have fewer side effects than traditional treatments. Genomics has enabled the development of personalized treatments that are tailored to the individual patient's genetic makeup. This has allowed for the development of drugs that target specific mutations or pathways, leading to more effective treatments.
The Targeted Therapies market is a rapidly growing field, with many companies investing in research and development. Companies such as Gilead Sciences, Novartis, and AstraZeneca are leading the way in the development of targeted therapies. Other companies such as Merck, Pfizer, and Roche are also investing in the development of targeted therapies. Show Less Read more